Anhedonia and ambivalence in schizophrenic patients with fronto-cerebellar metabolic abnormalities: A fluoro-D-glucose positron emission tomography study

Psychiatry Investigation

Volumn 6, Issue 2, 2009, Pages 72-77

  Park, Kyung Min ^a   Kim, Jae Jin ^a,b   Jeong, Ho Seok ^c   Ji, Won Chun ^a   Park, Hae Jeong ^b   Jong, Doo Lee ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Hallym University   (South Korea)

Author keywords

Ambivalence; Anhedonia; Fluoro D glucose positron emission tomography; Fronto cerebellar abnormalities; Schizophrenia

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AMBIVALENCE; ANHEDONIA; ARTICLE; BRAIN DYSFUNCTION; BRAIN FUNCTION; BRAIN METABOLISM; BRAIN REGION; CEREBELLUM; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE DURATION; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; RATING SCALE; SCHIZOPHRENIA; SELF REPORT;

EID: 67651174673     PISSN: 17383684     EISSN: None     Source Type: Journal    
DOI: 10.4306/pi.2009.6.2.72     Document Type: Article

References (35)

1. Andreasen NC, Carpenter WT Jr. Diagnosis and classification of schizophrenia. Schizophr Bull 1993;19:199-214.
2. Mann MC, Vaughn AG, Barrantes-Vidal N, Raulin ML, Kwapil TR. The schizotypal ambivalence scale as a marker of schizotypy. J Nerv Ment Dis 2008;196:399-404. (Pubitemid 351684750)
3. Gard DE, Kring AM, Gard MG, Horan WP, Green MF. Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure. Schizophr Res 2007;93:253-260.
4. van Harreveld F, van der Pligt J, de Liver YN. The agony of ambivalence and ways to resolve it: introducing the MAID model. Pers Soc Psychol Rev 2009;13:45-61.
5. Crespo-Facorro B, Paradiso S, Andreasen NC, O'Leary DS, Watkins GL, Ponto LL, et al. Neural mechanisms of anhedonia in schizophrenia: a PET study of response to unpleasant and pleasant odors. JAMA 2001;286:427-435.
6. Andreasen NC, Pierson R. The role of the cerebellum in schizophrenia. Biol Psychiatry 2008;64:81-88.
7. Middleton FA, Strick PL. Anatomical evidence for cerebellar and basal ganglia involvement in higher cognitive function. Science 1994;266:458-461.
8. Middleton FA, Strick PL. Cerebellar projections to the prefrontal cortex of the primate. J Neurosci 2001;21:700-712. (Pubitemid 32107458)
9. Kim JJ, Mohamed S, Andreasen NC, O'Leary DS, Watkins GL, Boles Ponto LL, et al. Regional neural dysfunctions in chronic schizophrenia studied with positron emission tomography. Am J Psychiatry 2000;157:542-548. (Pubitemid 30191192)
10. Allen G, Buxton RB, Wong EC, Courchesne E. Attentional activational of the cerebellum independent of motor involvement. Science 1997;275:1940-1943.
11. Raichle ME, Fiez JA, Videen TO, MacLeod AM, Pardo JV, Fox PT, et al. Practice-related changes in human brain functional anatomy during nonmotor learning. Cereb Cortex 1994;4:8-26.
12. Kim JJ, Andreasen NC, O'Leary DS, Wiser AK, Ponto LL, Watkins GL, et al. Direct comparison of the neural substrates of recognition memory for words and faces. Brain 1999;122(Pt 6):1069-1083.
13. Crespo-Facorro B, Nopoulos PC, Chemerinski E, Kim JJ, Andreasen NC, Magnotta V. Temporal pole morphology and psychopathology in males with schizophrenia. Psychiatry Res 2004;132:107-115. (Pubitemid 39643008)
14. Andreasen NC, O'Leary DS, Flaum M, Nopoulos P, Watkins GL, Boles Ponto LL, et al. Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naive patients. Lancet 1997;349:1730-1734. (Pubitemid 27252672)
15. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders. New York: New York State Psychiatric Institute Biometrics Research; 1996.
16. Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 2003;64:663-667.
17. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-276.
18. Chapman LJ, Chapman JP, Raulin ML. Scales for physical and social anhedonia. J Abnorm Psychol 1976;85:374-382.
19. Raulin ML, Brenner V. Ambivalence. In: Costello CG, editors. Symptoms of schizophrenia. New York: Wiley, 1993, p.201-226.
20. Kring AM, Smith DA, Neale JM. Individual differences in dispositional expressiveness: development and validation of the Emotional Expressivity Scale. J Pers Soc Psychol 1994;66:934-949.
21. Kinaha PE, Rogers JG. Analytic 3D image reconstruction using all detected events. IEEE T Nucl Sci 1989;36:964-968.
22. Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. New York: Thieme; 1988.
23. Weinberger DR, Berman KF, Zee RF. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch Gen Psychiatry 1986;43:114-124.
24. Toone BK, Okocha CI, Sivakumar K, Syed GM. Changes in regional cerebral blood flow due to cognitive activation among patients with schizophrenia. Br J Psychiatry 2000;177:222-228. (Pubitemid 30707554)
25. Andreasen NC, O'Leary DS, Cizadlo T, Arndt S, Rezai K, Ponto LL, et al. Schizophrenia and cognitive dysmetria: a positron-emission tomography study of dysfunctional prefrontal-thalamic-cerebellar circuitry. Proc Natl Acad Sci U S A 1996;93:9985-9990.
26. Heerey EA, Robinson BM, McMahon RP, Gold JM. Delay discounting in schizophrenia. Cogn Neuropsychiatry 2007;12:213-221.
27. Juckel G, Schlagenhauf F, Koslowski M, Wüstenberg T, Villringer A, Knutson B, et al. Dysfunction of ventral striatal reward prediction in schizophrenia. Neuroimage 2006;29:409-416. (Pubitemid 43063297)
28. Juckel G, Schlagenhauf F, Koslowski M, Filonov D, Wüstenberg T, Villringer A, et al. Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics. Psychopharmacology (Berl) 2006;187:222-228. (Pubitemid 44015616)
29. Murray GK, Corlett PR, Clark L, Pessiglione M, Blackwell AD, Honey G, et al. How dopamine dysregulation leads to psychotic symptoms? Abnormal mesolimbic and mesostriatal prediction error signalling in psychosis. Mol Psychiatry 2008;13:239. (Pubitemid 351272662)
30. Murray GK, Corlett PR, Clark L, Pessiglione M, Blackwell AD, Honey G, et al. Substantia nigra/ventral tegmental reward prediction error disruption in psychosis. Mol Psychiatry 2008;13:239, 267-276. (Pubitemid 351272654)
31. Henry JD, Green MJ, de Lucia A, Restuccia C, McDonald S, O'Donnell M. Emotion dysregulation in schizophrenia: reduced amplification of emotional expression is associated with emotional blunting. Schizophr Res 2007;95:197-204.
32. Berman KF, Torrey EF, Daniel DG, Weinberger DR. Regional cerebral blood flow in monozygotic twins discordant and concordant for schizophrenia. Arch Gen Psychiatry 1992;49:927-934.
33. Warren JE, Sauter DA, Eisner F, Wiland J, Dresner MA, Wise RJ, et al. Positive emotions preferentially engage an auditory-motor "mirror" system. J Neurosci 2006;26:13067-13075.
34. Holcomb HH, Cascella NG, Thaker GK, Medoff DR, Dannals RF, Tamminga CA. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. Am J Psychiatry 1996;153:41-49.
35. Loeber RT, Gruber SA, Cohen BM, Renshaw PF, Sherwood AR, Yurgelun-Todd DA. Cerebellar blood volume in bipolar patients correlates with medication. Biol Psychiatry 2002;51:370-376.